Captagon trafficking and the role of Europe


This report examines the role of Europe in the production and trafficking of captagon tablets. It includes an historical background, current production and trafficking, seizures, the consumer market, production within the EU, forensic analysis and purported links to terrorism. The report is the culmination of operational action 1.2 of the European Multidisciplinary Platform Against Criminal Threats (EMPACT) Synthetic Drugs and NPS operational action plan of 2022, ‘Improve and analyse the criminal intelligence picture on the production and trafficking of captagon tablets and the role of Europe’. The action was led by Germany (Bundeskriminalamt, BKA) and the EMCDDA.

Download as PDF

Table of contents

  • Introduction
  • Historical background
  • Production and trafficking of captagon
  • Consumer markets for captagon
  • Seizures of captagon in the European Union
  • Seizures of captagon tablets overseas with links to the European Union
  • Production of captagon tablets in the European Union
  • Forensic analysis of captagon tablets
  • No evidence of links to the Islamic State terrorist organisation
  • Links to the Syrian regime
  • Conclusions and recommendations
  • Supplementary information
  • Annex 1
  • References